Ranbaxy gets approval to market Ran-Rosuvastatin drug in Canada
Quotes

Ranbaxy gets approval to market Ran-Rosuvastatin drug in Canada

Last Updated: Saturday, March 31, 2012, 13:30
 
 Comment 0
 
Ranbaxy gets approval to market Ran-Rosuvastatin drug in Canada
Mumbai: Indian generic drug maker Ranbaxy Laboratories Ltd. said Saturday that its subsidiary in Canada got an approval from Health Canada to manufacture and market Ran-Rosuvastatin tablets, a cholesterol-lowering medication, to the Canadian healthcare system.

Ranbaxy said the approval for this molecule will provide an affordable alternative to the brand Crestor in Canada, which had sales of USD 742.2 million in 2011.

"We anticipate making Rosuvastatin tablets available to all classes of trade after April 2 when sufficient supplies are available to meet market demand," said Paul Drake, president and general manager of Ranbaxy Pharmaceuticals Canada Inc., the subsidiary of Ranbaxy Laboratories.

The finished dosage form will be manufactured within Ranbaxy Laboratories's Health Canada approved facilities located in India, said Drake.

Bureau Report



First Published: Saturday, March 31, 2012, 13:30


Comments


comments powered by Disqus
G20 Summit 2014
G20 Summit 2014
2014`s Top People in Business: Fortune
2014`s Top People in Business: Fortune
World Bank`s Top 10 Places for Business
World Bank`s Top 10 Places for Business
India`s top ten billionaires
India`s top ten billionaires
Top 10 billionaire cities- In Pics
Top 10 billionaire cities- In Pics

Web Wrap
Contact Us : Privacy Policy : Legal Disclaimer
Copyright © Zee Media Corporation Ltd. All rights reserved